An experimental vaccine against the new coronavirus developed at the University of Oxford will be tested from mid-June in Brazil, the first country outside Britain to take part in the study, researchers said Wednesday.
The vaccine will be tested in Brazil on 2,000 volunteers, who will be recruited starting this week, said the Federal University of Sao Paulo, which is coordinating the study.
Volunteers “must be health professionals between 18 and 55 years old and be at high risk of infection, for example, cleaning and support staff in units treating COVID-19 patients,” the Brazilian university’s president, Soraya Smaili, told AFP.
Testing the vaccine in Brazil “is very important because we are in the acceleration phase of the epidemiological curve,” she added.
Brazil is the latest epicenter in the coronavirus pandemic.
The country of 210 million people is now second only to the United States in total cases, with more than 555,000, and has registered more than 31,000 deaths, the fourth-highest toll in the world, after the US, Britain and Italy.
Experts say under-testing means the real figures in Brazil are probably much higher.
Testing is due to start in Brazil the second week in June and expand to other countries after that, the university said.
“The results will be fundamental for the vaccine’s approval in the United Kingdom, expected late this year,” it added.
Oxford is partnering with British pharmaceuticals group AstraZeneca to develop and distribute the vaccine, one of several that researchers around the world are racing to test.
Brazil surges to second in coronavirus cases worldwide
© 2020 AFP
Brazil to help test Oxford coronavirus vaccine (2020, June 3)
retrieved 3 June 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- “We Have Increased Covid Testing By Three Times”: Delhi Health Minister - September 27, 2020
- Johnson & Johnson COVID-19 Vaccine Produces Strong Immune Response In Early Trial - September 27, 2020
- Jaswant Singh Cremated In Jodhpur, Family, Leaders Pay Last Respects - September 27, 2020
- India’s Coronavirus Tally Nears 60 Lakh-Mark, 88,600 New Cases In A Day - September 27, 2020
- Family Alleges Rats Bit Body Of Man Who Died Of Covid At Indore Hospital - September 22, 2020
- Vaccine Likely For India In Early 2021, Roll-Out A Challenge: Scientist - September 22, 2020
- COVID-19 recovery rate in India crosses 80 per cent mark - September 21, 2020
- 86,961 new COVID-19 cases in India, tally reaches 54,87,580 - September 21, 2020
- World Alzheimer’s Day 2020: Simple Tips - September 21, 2020
- COVID-19 cases in India cross 46-lakh mark - September 12, 2020